Professor Ben Cooper
Contact information
Podcast interview
Drug-resistant infections and disease dynamics
Infectious diseases carry a huge impact and developing interventions remains a priority. A recent trial in Southeast Asia aimed at shortening antibiotic treatment for ventilator-associated pneumonia, reducing side effects and the risk of antimicrobial resistance. Collaborations underline the global AMR burden and the need for effective solutions, from improved antibiotics use to novel diagnostics and vaccines, crucial amid rising challenges.
Ben Cooper
Professor of Epidemiology
Ben Cooper's work uses mathematical and statistical modelling, observational studies and clinical trials to help understand the burden and dynamics of infectious diseases and evaluate potential control measures. His current work focuses on drug-resistant infections and emerging pathogens. He leads the Drug-Resistant Infection and Disease Dynamics group (DRIaDD).
Recent publications
-
Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study.
Waterlow NR. et al, (2024), PLoS Med, 21
-
Carbapenemase-producing Enterobacterales colonisation status does not lead to more frequent admissions: a linked patient study
Lydeamore MJ. et al, (2024)
-
Natural immune boosting can cause synchrony in susceptibility and outbreaks of respiratory infections with rapidly waning immunity
Pritchard MG. et al, (2023)
-
The burden and dynamics of hospital-acquired SARS-CoV-2 in England
Cooper BS. et al, (2023), Nature, 623, 132 - 138
-
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
Cavany S. et al, (2023), Nature Communications, 14